111 Capital Amicus Therapeutics, Inc. Transaction History
111 Capital
- $582 Billion
- Q2 2025
A detailed history of 111 Capital transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, 111 Capital holds 13,355 shares of FOLD stock, worth $93,217. This represents 0.01% of its overall portfolio holdings.
Number of Shares
13,355Holding current value
$93,217% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding FOLD
# of Institutions
313Shares Held
329MCall Options Held
437KPut Options Held
450K-
Vanguard Group Inc Valley Forge, PA29.4MShares$205 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA29.1MShares$203 Million0.03% of portfolio
-
Black Rock Inc. New York, NY24.4MShares$170 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY18MShares$126 Million1.88% of portfolio
-
William Blair Investment Management, LLC Chicago, IL14.6MShares$102 Million0.24% of portfolio
About AMICUS THERAPEUTICS, INC.
- Ticker FOLD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 280,497,984
- Market Cap $1.96B
- Description
- Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...